Orange Ventures invests in French health-tech startup Biolevate in financing round

• Orange Ventures invested in French health-tech start-up Biolevate in its latest financing round, taking a minority stake.
• Deal targets life sciences automation, aiming to speed drug development workflows using Biolevate’s agentic AI platform.
• Orange Business will partner with Biolevate, combining its technology with Enovalife’s clinical research, data, and AI transformation services.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orange SA published the original content used to generate this news brief on September 22, 2026, and is solely responsible for the information contained therein.